Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Keefer Jason | Interim President and CEO | 4 | $0 | $0 | 2019-04-17 |
| Danilkovitch Alla | Chief Scientific Officer | 19 | $0 | $44.2K | 2019-04-17 |
| FRIEDLI PETER | Director, 10% Owner | 13 | $0 | $481.8K | 2019-04-17 |
| VENTURETEC INC | Other | 3 | $0 | $476.0K | 2018-07-24 |
| CHANG LINDA L | Chief Financial Officer | 2 | $0 | $0 | 2018-03-06 |
| VERNAL SHAUNA L | Chief Legal Officer | 1 | $0 | $0 | 2018-03-06 |
| Palczuk Linda | President & CEO | 1 | $0 | $0 | 2017-07-10 |
| Avendano Rodrigo Alberto | Chief Medical Officer | 4 | $0 | $0 | 2017-01-27 |
| DRESNER DAVID A | Interim President & CEO | 14 | $0 | $0 | 2017-01-25 |
| Montgomery Bobby Dwayne | Chief Executive Officer | 11 | $0 | $0 | 2016-06-09 |
| Hopper Jonathan Mark | Chief Medical Officer | 6 | $0 | $0 | 2016-04-12 |
| Czworka Frank D Jr | Vice President | 10 | $0 | $0 | 2016-03-09 |
| Debrabandere Lode | Senior Vice President | 21 | $0 | $0 | 2016-02-22 |
| JACOBY PHILIP R JR | Principal Accounting Officer | 27 | $0 | $910.8K | 2016-01-08 |
| LAW GREGORY IVAN | Principal Accounting Officer | 1 | $1.9K | $0 | 2015-06-04 |
| Neumayer Matthew Paul | Principal Accounting Officer | 37 | $0 | $353.2K | 2014-09-30 |
| Williams Michelle LeRoux | Chief Scientific Officer | 33 | $208 | $1.26M | 2014-04-15 |
| Klingemann Hans-Georg | Director | 2 | $0 | $0 | 2014-02-06 |
| Gutzwiller Felix | Director | 3 | $0 | $0 | 2014-02-06 |
| Mills C Randal | President & CEO | 10 | $0 | $0 | 2013-12-03 |
| MOYES JAY M | Director | 3 | $0 | $0 | 2013-02-12 |
| Potter Stephen W | Senior Vice President | 2 | $0 | $0 | 2012-03-23 |
| BARNHILL GREGORY HURD | Director | 1 | $0 | $0 | 2012-03-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 10,000 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 8,000 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 5,000 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 24,997 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 17,356 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 7,644 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 18,564 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 1,436 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 25,003 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 6,000 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 9,000 | — | $0 | 0 | SEC↗ |
| Keefer Jason | Chief Commercial Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 16,000 | — | $0 | 0 | SEC↗ |
| Keefer Jason | Chief Commercial Officer | D To issuer deriv | 2019-04-17 | 2019-04-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | D To issuer | 2019-04-17 | 2019-04-17 | 9,375 | $19.00 | $178.1K | 0 | SEC↗ |
| Keefer Jason | Chief Commercial Officer | D To issuer | 2019-04-17 | 2019-04-17 | 4,000 | $19.00 | $76.0K | 0 | SEC↗ |
| FRIEDLI PETER | Director | D To issuer | 2019-04-17 | 2019-04-17 | 2,750 | $19.00 | $52.3K | 0 | SEC↗ |
| FRIEDLI PETER | Director | D To issuer | 2019-04-17 | 2019-04-17 | 4,103,301 | $19.00 | $77.96M | 0 | SEC↗ |
| FRIEDLI PETER | Director | D To issuer | 2019-04-17 | 2019-04-17 | 500,000 | $19.00 | $9.50M | 0 | SEC↗ |
| FRIEDLI PETER | Director | D To issuer | 2019-04-17 | 2019-04-17 | 10,204,404 | $19.00 | $193.88M | 0 | SEC↗ |
| VENTURETEC INC | Other | J Other | 2018-07-24 | 2018-07-25 | 3,000,000 | — | $0 | 0 | SEC↗ |
| VENTURETEC INC | 10% Owner | J Other | 2018-07-05 | 2018-07-09 | 1,103,301 | — | $0 | 3,000,000 | SEC↗ |
| Keefer Jason | Interim President and CEO | A Award deriv | 2018-06-26 | 2018-06-28 | 20,000 | — | $0 | 36,000 | SEC↗ |
| CHANG LINDA L | Chief Financial Officer | A Award deriv | 2018-03-06 | 2018-03-08 | 10,000 | — | $0 | 30,000 | SEC↗ |
| VERNAL SHAUNA L | Chief Legal Officer | A Award deriv | 2018-03-06 | 2018-03-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHANG LINDA L | Chief Financial Officer | A Award deriv | 2018-02-26 | 2018-02-28 | 20,000 | $8.92 | $178.4K | 20,000 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | A Award deriv | 2017-07-19 | 2017-09-28 | 34,534 | $6.80 | $234.8K | 125,534 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | A Award deriv | 2017-07-19 | 2017-09-28 | 15,466 | $6.80 | $105.2K | 139,000 | SEC↗ |
| Palczuk Linda | President & CEO | A Award deriv | 2017-07-10 | 2017-09-21 | 25,000 | $6.67 | $166.8K | 25,000 | SEC↗ |
| Avendano Rodrigo Alberto | Chief Medical Officer | D To issuer deriv | 2017-01-27 | 2017-01-31 | 5,000 | $4.96 | $24.8K | 5,000 | SEC↗ |
| Avendano Rodrigo Alberto | Chief Medical Officer | D To issuer deriv | 2017-01-27 | 2017-01-31 | 5,000 | $4.96 | $24.8K | 15,000 | SEC↗ |
| Avendano Rodrigo Alberto | Chief Medical Officer | D To issuer deriv | 2017-01-27 | 2017-01-31 | 5,000 | $4.96 | $24.8K | 10,000 | SEC↗ |
| Avendano Rodrigo Alberto | Chief Medical Officer | D To issuer deriv | 2017-01-27 | 2017-01-31 | 5,000 | $4.96 | $24.8K | 0 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise deriv | 2017-01-25 | 2017-01-26 | 5,000 | $5.12 | $25.6K | 10,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise | 2017-01-25 | 2017-01-26 | 5,000 | $5.12 | $25.6K | 15,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise | 2017-01-25 | 2017-01-26 | 5,000 | $5.30 | $26.5K | 25,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise | 2017-01-25 | 2017-01-26 | 5,000 | $5.48 | $27.4K | 20,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise deriv | 2017-01-23 | 2017-01-24 | 5,000 | $5.03 | $25.1K | 15,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise | 2017-01-23 | 2017-01-24 | 5,000 | $5.03 | $25.1K | 10,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise deriv | 2017-01-12 | 2017-01-17 | 5,000 | $4.75 | $23.8K | 20,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise | 2017-01-12 | 2017-01-17 | 5,000 | $4.75 | $23.8K | 5,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | A Award deriv | 2016-10-10 | 2016-10-11 | 5,000 | $4.75 | $23.8K | 25,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | A Award deriv | 2016-09-12 | 2016-09-12 | 5,000 | $5.30 | $26.5K | 20,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | A Award deriv | 2016-08-10 | 2016-08-10 | 5,000 | $5.48 | $27.4K | 15,000 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | A Award deriv | 2016-07-10 | 2016-07-11 | 5,000 | $5.03 | $25.1K | 10,000 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 3,125 | $18.40 | $57.5K | 25,625 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 2,500 | $7.39 | $18.5K | 18,125 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 2,500 | $7.39 | $18.5K | 20,625 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 2,500 | $7.39 | $18.5K | 23,125 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 2,500 | $7.39 | $18.5K | 15,625 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 3,125 | $18.40 | $57.5K | 28,750 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 3,125 | $18.40 | $57.5K | 31,875 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 6,250 | $12.39 | $77.4K | 35,000 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | D To issuer deriv | 2016-06-09 | 2016-06-13 | 6,250 | $12.39 | $77.4K | 41,250 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-14 | 6,250 | $13.12 | $82.0K | 6,250 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-14 | 6,250 | $13.12 | $82.0K | 12,500 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-14 | 6,250 | $13.12 | $82.0K | 18,750 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-15 | 6,250 | $13.12 | $82.0K | 12,500 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-15 | 6,250 | $13.12 | $82.0K | 6,250 | SEC↗ |
| Hopper Jonathan Mark | Chief Medical Officer | D To issuer deriv | 2016-04-12 | 2016-04-15 | 6,250 | $13.12 | $82.0K | 18,750 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 5,000 | $7.73 | $38.6K | 95,000 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 5,434 | $18.40 | $100.0K | 53,750 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 9,430 | $15.58 | $146.9K | 85,570 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 13,070 | $15.58 | $203.6K | 72,500 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 13,316 | $18.40 | $245.0K | 59,184 | SEC↗ |
| Czworka Frank D Jr | Vice President | D To issuer deriv | 2016-03-09 | 2016-03-14 | 3,750 | $5.08 | $19.1K | 100,000 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | A Award deriv | 2016-03-04 | 2016-03-07 | 10,000 | $7.39 | $73.9K | 47,500 | SEC↗ |
| Montgomery Bobby Dwayne | Chief Executive Officer | A Award deriv | 2016-03-04 | 2016-03-14 | 10,000 | $7.39 | $73.9K | 47,500 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 18,750 | $18.40 | $345.0K | 283,750 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 30,803 | $14.93 | $459.9K | 330,761 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 2,814 | $14.93 | $42.0K | 327,947 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 7,500 | $7.73 | $58.0K | 396,250 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 13,316 | $18.40 | $245.0K | 251,684 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 5,434 | $18.40 | $100.0K | 246,250 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 6,250 | $5.08 | $31.8K | 403,750 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 18,750 | $18.40 | $345.0K | 265,000 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 6,697 | $14.93 | $100.0K | 321,250 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 18,750 | $18.40 | $345.0K | 302,500 | SEC↗ |
| Debrabandere Lode | President & CEO | D To issuer deriv | 2016-02-22 | 2016-02-24 | 34,686 | $14.93 | $517.9K | 361,564 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise deriv | 2016-01-25 | 2017-01-26 | 5,000 | $5.30 | $26.5K | 0 | SEC↗ |
| DRESNER DAVID A | Interim President & CEO | M Exercise deriv | 2016-01-25 | 2017-01-26 | 5,000 | $5.48 | $27.4K | 5,000 | SEC↗ |
| JACOBY PHILIP R JR | Principal Accounting Officer | D To issuer deriv | 2016-01-08 | 2016-01-08 | 5,000 | $5.08 | $25.4K | 54,181 | SEC↗ |
| JACOBY PHILIP R JR | Principal Accounting Officer | D To issuer deriv | 2016-01-08 | 2016-01-08 | 10,000 | $7.73 | $77.3K | 44,181 | SEC↗ |
| Debrabandere Lode | President & CEO | M Exercise deriv | 2015-11-20 | 2015-11-20 | 37,500 | $6.84 | $256.5K | 410,000 | SEC↗ |
| Debrabandere Lode | President & CEO | M Exercise | 2015-11-20 | 2015-11-20 | 37,500 | $6.84 | $256.5K | 37,500 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | M Exercise deriv | 2015-11-19 | 2015-11-20 | 4,000 | $5.08 | $20.3K | 89,000 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | M Exercise | 2015-11-19 | 2015-11-20 | 4,000 | $5.08 | $20.3K | 11,950 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | M Exercise deriv | 2015-08-10 | 2015-08-11 | 5,000 | $0.40 | $2.0K | 93,000 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | S Sale | 2015-08-10 | 2015-08-11 | 2,425 | $18.22 | $44.2K | 7,950 | SEC↗ |
| Danilkovitch Alla | Chief Scientific Officer | M Exercise | 2015-08-10 | 2015-08-11 | 5,000 | $0.40 | $2.0K | 10,375 | SEC↗ |
| LAW GREGORY IVAN | Principal Accounting Officer | P Buy | 2015-06-04 | 2015-06-08 | 100 | $18.83 | $1.9K | 100 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2015-05-27 | 2015-05-29 | 11,389 | $7.74 | $88.2K | 67,792 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2015-05-27 | 2015-05-29 | 3,751 | $6.46 | $24.2K | 64,041 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2015-05-27 | 2015-05-29 | 4,860 | $7.13 | $34.7K | 59,181 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2015-05-27 | 2015-05-29 | 4,860 | $7.13 | $34.7K | 32,500 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2015-05-27 | 2015-05-29 | 3,751 | $6.46 | $24.2K | 27,640 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2015-05-27 | 2015-05-29 | 11,389 | $7.74 | $88.2K | 23,889 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | S Sale | 2015-05-27 | 2015-05-29 | 20,000 | $18.55 | $371.0K | 12,500 | SEC↗ |
| Debrabandere Lode | President & CEO | A Award deriv | 2015-03-06 | 2015-03-09 | 5,434 | $18.40 | $100.0K | 377,934 | SEC↗ |
| Debrabandere Lode | President & CEO | A Award deriv | 2015-03-06 | 2015-03-09 | 69,566 | $18.40 | $1.28M | 447,500 | SEC↗ |
| Czworka Frank D Jr | Vice President | A Award deriv | 2015-03-06 | 2015-03-09 | 19,566 | $18.40 | $360.0K | 103,750 | SEC↗ |
| Czworka Frank D Jr | Vice President | A Award deriv | 2015-03-06 | 2015-03-09 | 5,434 | $18.40 | $100.0K | 84,184 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | D To issuer deriv | 2014-09-30 | 2014-10-02 | 2,625 | $7.73 | $20.3K | 0 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | D To issuer deriv | 2014-09-30 | 2014-10-02 | 1,000 | $7.13 | $7.1K | 4,375 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | D To issuer deriv | 2014-09-30 | 2014-10-02 | 1,750 | $5.08 | $8.9K | 2,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-29 | 2014-05-30 | 500 | $6.46 | $3.2K | 5,375 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | S Sale | 2014-05-29 | 2014-05-30 | 500 | $15.55 | $7.8K | 0 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-29 | 2014-05-30 | 500 | $6.46 | $3.2K | 500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-29 | 1,000 | $7.13 | $7.1K | 8,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-29 | 1,000 | $7.74 | $7.7K | 7,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-29 | 875 | $5.08 | $4.4K | 6,750 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-29 | 875 | $7.73 | $6.8K | 5,875 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-30 | 875 | $5.08 | $4.4K | 6,750 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-30 | 1,000 | $7.74 | $7.7K | 7,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-30 | 1,000 | $7.13 | $7.1K | 8,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2014-05-27 | 2014-05-30 | 875 | $7.73 | $6.8K | 5,875 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-29 | 875 | $7.73 | $6.8K | 6,750 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-29 | 1,000 | $7.13 | $7.1K | 9,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-29 | 1,000 | $7.74 | $7.7K | 8,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-29 | 875 | $5.08 | $4.4K | 7,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | S Sale | 2014-05-27 | 2014-05-29 | 3,750 | $16.10 | $60.4K | 5,875 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-30 | 1,000 | $7.74 | $7.7K | 2,000 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | S Sale | 2014-05-27 | 2014-05-30 | 3,750 | $16.10 | $60.4K | 0 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-30 | 875 | $5.08 | $4.4K | 2,875 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-30 | 1,000 | $7.13 | $7.1K | 1,000 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2014-05-27 | 2014-05-30 | 875 | $7.73 | $6.8K | 3,750 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2014-05-21 | 2014-05-23 | 2,336 | $5.08 | $11.9K | 84,181 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2014-05-21 | 2014-05-23 | 5,000 | $7.73 | $38.6K | 79,181 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2014-05-21 | 2014-05-23 | 8,611 | $7.74 | $66.6K | 86,517 | SEC↗ |
| Czworka Frank D Jr | Vice President | M Exercise deriv | 2014-05-21 | 2014-05-23 | 13,339 | $15.58 | $207.8K | 62,089 | SEC↗ |
| Czworka Frank D Jr | Vice President | M Exercise deriv | 2014-05-21 | 2014-05-23 | 16,661 | $15.58 | $259.6K | 78,750 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2014-05-21 | 2014-05-23 | 8,611 | $7.74 | $66.6K | 21,111 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2014-05-21 | 2014-05-23 | 2,336 | $5.08 | $11.9K | 23,477 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2014-05-21 | 2014-05-23 | 5,000 | $7.73 | $38.6K | 28,447 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | S Sale | 2014-05-21 | 2014-05-23 | 15,947 | $15.43 | $246.1K | 12,500 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | H Expire deriv | 2014-04-15 | 2014-04-15 | 15,564 | $7.73 | $120.3K | 68,752 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | H Expire deriv | 2014-04-15 | 2014-04-15 | 12,500 | $5.08 | $63.5K | 84,316 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | H Expire deriv | 2014-04-15 | 2014-04-15 | 6,250 | $7.13 | $44.6K | 96,816 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | H Expire deriv | 2014-04-15 | 2014-04-15 | 3,750 | $6.46 | $24.2K | 103,066 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | H Expire deriv | 2014-04-15 | 2014-04-15 | 3,186 | $7.73 | $24.6K | 65,566 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-14 | 2014-03-17 | 7,746 | $12.01 | $93.0K | 111,004 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-14 | 2014-03-17 | 4,188 | $12.01 | $50.3K | 106,896 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | S Sale | 2014-03-14 | 2014-03-17 | 11,934 | $13.91 | $166.0K | 0 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2014-03-14 | 2014-03-17 | 11,934 | $12.01 | $143.3K | 11,934 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 14,908 | $7.13 | $106.3K | 128,842 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 6,253 | $7.74 | $48.4K | 143,750 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 18,747 | $7.74 | $145.1K | 150,003 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 3,842 | $7.13 | $27.4K | 125,000 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 6,249 | $5.08 | $31.7K | 118,751 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2014-03-13 | 2014-03-17 | 1 | $5.08 | $5 | 118,750 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2014-03-13 | 2014-03-17 | 18,750 | $7.13 | $133.7K | 43,750 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | S Sale | 2014-03-13 | 2014-03-17 | 50,000 | $14.14 | $707.0K | 0 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2014-03-13 | 2014-03-17 | 6,250 | $5.08 | $31.8K | 50,000 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2014-03-13 | 2014-03-17 | 25,000 | $7.74 | $193.5K | 25,000 | SEC↗ |
| Debrabandere Lode | President & CEO | A Award deriv | 2014-02-06 | 2014-02-07 | 139,801 | $14.93 | $2.09M | 372,500 | SEC↗ |
| Debrabandere Lode | President & CEO | A Award deriv | 2014-02-06 | 2014-02-07 | 10,199 | $14.93 | $152.3K | 232,699 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | A Award | 2014-02-06 | 2014-02-07 | 10,000 | $14.93 | $149.3K | 10,204,404 | SEC↗ |
| Gutzwiller Felix | Director | A Award | 2014-02-06 | 2014-02-07 | 7,000 | $14.93 | $104.5K | 84,500 | SEC↗ |
| Klingemann Hans-Georg | Director | A Award | 2014-02-06 | 2014-02-07 | 5,000 | $14.93 | $74.7K | 6,250 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | J Other | 2014-01-17 | 2014-01-21 | 0 | — | $0 | 4,606,051 | SEC↗ |
| Mills C Randal | President & CEO | H Expire deriv | 2013-12-03 | 2013-12-03 | 6,831 | $7.13 | $48.7K | 593,169 | SEC↗ |
| Mills C Randal | President & CEO | H Expire deriv | 2013-12-03 | 2013-12-03 | 10,000 | $7.74 | $77.4K | 60,000 | SEC↗ |
| Mills C Randal | President & CEO | H Expire deriv | 2013-12-03 | 2013-12-03 | 18,712 | $7.73 | $144.6K | 550,000 | SEC↗ |
| Mills C Randal | President & CEO | H Expire deriv | 2013-12-03 | 2013-12-03 | 11,288 | $7.73 | $87.3K | 568,712 | SEC↗ |
| Mills C Randal | President & CEO | H Expire deriv | 2013-12-03 | 2013-12-03 | 13,169 | $7.13 | $93.9K | 580,000 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2013-11-25 | 2013-11-26 | 9,624 | $7.13 | $68.6K | 100,127 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2013-11-25 | 2013-11-26 | 4,999 | $5.08 | $25.4K | 95,128 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise deriv | 2013-11-25 | 2013-11-26 | 3,749 | $6.46 | $24.2K | 109,751 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | S Sale | 2013-11-25 | 2013-11-26 | 18,372 | $15.99 | $293.8K | 12,500 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2013-11-25 | 2013-11-26 | 4,999 | $5.08 | $25.4K | 30,872 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2013-11-25 | 2013-11-26 | 9,624 | $7.13 | $68.6K | 25,873 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | M Exercise | 2013-11-25 | 2013-11-26 | 3,749 | $6.46 | $24.2K | 16,249 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2013-11-15 | 2013-11-18 | 5,750 | $0.40 | $2.3K | 187,500 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2013-11-15 | 2013-11-18 | 7,500 | $0.40 | $3.0K | 180,000 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2013-11-15 | 2013-11-18 | 11,250 | $6.46 | $72.7K | 168,750 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2013-11-15 | 2013-11-18 | 7,500 | $0.40 | $3.0K | 13,250 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2013-11-15 | 2013-11-18 | 11,250 | $6.46 | $72.7K | 24,500 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise | 2013-11-15 | 2013-11-18 | 5,750 | $0.40 | $2.3K | 5,750 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | S Sale | 2013-11-15 | 2013-11-18 | 24,500 | $15.50 | $379.8K | 0 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2013-08-20 | 2013-08-20 | 1,500 | $6.46 | $9.7K | 17,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2013-08-20 | 2013-08-20 | 2,000 | $7.13 | $14.3K | 19,000 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2013-08-20 | 2013-08-20 | 4,000 | $16.75 | $67.0K | 10,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2013-08-20 | 2013-08-20 | 875 | $5.08 | $4.4K | 9,625 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise deriv | 2013-08-20 | 2013-08-20 | 3,000 | $7.74 | $23.2K | 14,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2013-08-20 | 2013-08-20 | 4,000 | $16.75 | $67.0K | 10,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2013-08-20 | 2013-08-20 | 1,500 | $6.46 | $9.7K | 3,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2013-08-20 | 2013-08-20 | 3,000 | $7.74 | $23.2K | 6,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2013-08-20 | 2013-08-20 | 875 | $5.08 | $4.4K | 11,375 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | S Sale | 2013-08-20 | 2013-08-20 | 11,375 | $19.75 | $224.7K | 0 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | M Exercise | 2013-08-20 | 2013-08-20 | 2,000 | $7.13 | $14.3K | 2,000 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | M Exercise deriv | 2013-08-14 | 2013-08-16 | 1,000,000 | — | $0 | 0 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | M Exercise | 2013-08-14 | 2013-08-16 | 1,000,000 | $11.00 | $11.00M | 10,626,794 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | F Tax w/h | 2013-08-14 | 2013-08-16 | 432,390 | $25.44 | $11.00M | 10,194,404 | SEC↗ |
| Mills C Randal | President & CEO | A Award deriv | 2013-02-12 | 2013-02-13 | 11,288 | $7.73 | $87.3K | 610,000 | SEC↗ |
| Mills C Randal | President & CEO | A Award deriv | 2013-02-12 | 2013-02-13 | 18,712 | $7.73 | $144.6K | 598,712 | SEC↗ |
| Debrabandere Lode | Senior Vice President | A Award deriv | 2013-02-12 | 2013-02-13 | 11,936 | $7.73 | $92.3K | 222,500 | SEC↗ |
| Debrabandere Lode | Senior Vice President | A Award deriv | 2013-02-12 | 2013-02-13 | 18,064 | $7.73 | $139.6K | 210,564 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | A Award deriv | 2013-02-12 | 2013-02-13 | 9,436 | $7.73 | $72.9K | 193,250 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | A Award deriv | 2013-02-12 | 2013-02-13 | 15,564 | $7.73 | $120.3K | 183,814 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | A Award deriv | 2013-02-12 | 2013-02-13 | 15,000 | $7.73 | $116.0K | 108,500 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | A Award deriv | 2013-02-12 | 2013-02-13 | 5,000 | $7.73 | $38.6K | 113,500 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | A Award deriv | 2013-02-12 | 2013-02-13 | 3,500 | $7.73 | $27.1K | 21,000 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | A Award | 2013-02-12 | 2013-02-13 | 10,000 | $7.73 | $77.3K | 9,626,794 | SEC↗ |
| Gutzwiller Felix | Director | A Award | 2013-02-12 | 2013-02-13 | 7,000 | $7.73 | $54.1K | 77,500 | SEC↗ |
| MOYES JAY M | Director | A Award | 2013-02-12 | 2013-02-13 | 5,000 | $7.73 | $38.6K | 21,500 | SEC↗ |
| Klingemann Hans-Georg | Director | A Award | 2013-02-12 | 2013-02-13 | 1,250 | $7.73 | $9.7K | 1,250 | SEC↗ |
| MOYES JAY M | Director | A Award | 2013-02-06 | 2014-02-07 | 5,000 | $14.93 | $74.7K | 26,500 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | M Exercise deriv | 2012-12-11 | 2012-12-11 | 520 | $0.40 | $208 | 168,250 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | P Buy | 2012-12-11 | 2012-12-11 | 520 | $0.40 | $208 | 520 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | S Sale | 2012-12-11 | 2012-12-11 | 520 | $9.31 | $4.8K | 0 | SEC↗ |
| VENTURETEC INC | 10% Owner | S Sale | 2012-12-10 | 2012-12-10 | 50,000 | $9.52 | $476.0K | 4,103,301 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | S Sale | 2012-12-10 | 2012-12-10 | 50,000 | $9.52 | $476.0K | 4,606,051 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | S Sale | 2012-11-15 | 2012-11-16 | 625 | $9.34 | $5.8K | 4,656,051 | SEC↗ |
| Mills C Randal | President & CEO | A Award deriv | 2012-03-23 | 2012-04-06 | 0 | $5.08 | $0 | 580,000 | SEC↗ |
| Mills C Randal | President & CEO | A Award deriv | 2012-03-23 | 2012-03-27 | 11,900 | $5.08 | $60.5K | 591,900 | SEC↗ |
| Mills C Randal | President & CEO | A Award deriv | 2012-03-23 | 2012-03-27 | 13,100 | $5.08 | $66.5K | 605,000 | SEC↗ |
| Potter Stephen W | Senior Vice President | A Award deriv | 2012-03-23 | 2012-03-27 | 5,000 | $5.08 | $25.4K | 105,000 | SEC↗ |
| Potter Stephen W | Senior Vice President | A Award deriv | 2012-03-23 | 2012-03-27 | 15,000 | $5.08 | $76.2K | 120,000 | SEC↗ |
| Debrabandere Lode | Senior Vice President | A Award deriv | 2012-03-23 | 2012-03-27 | 12,502 | $5.08 | $63.5K | 217,502 | SEC↗ |
| Debrabandere Lode | Senior Vice President | A Award deriv | 2012-03-23 | 2012-03-27 | 12,498 | $5.08 | $63.5K | 230,000 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | A Award deriv | 2012-03-23 | 2012-03-27 | 12,498 | $5.08 | $63.5K | 168,770 | SEC↗ |
| Williams Michelle LeRoux | Chief Scientific Officer | A Award deriv | 2012-03-23 | 2012-03-27 | 12,502 | $5.08 | $63.5K | 156,272 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | A Award deriv | 2012-03-23 | 2012-03-27 | 7,335 | $5.08 | $37.3K | 106,000 | SEC↗ |
| JACOBY PHILIP R JR | Chief Financial Officer | A Award deriv | 2012-03-23 | 2012-03-27 | 12,665 | $5.08 | $64.3K | 98,665 | SEC↗ |
| Neumayer Matthew Paul | Principal Accounting Officer | A Award deriv | 2012-03-23 | 2012-03-27 | 3,500 | $5.08 | $17.8K | 17,500 | SEC↗ |
| FRIEDLI PETER | Director, 10% Owner | A Award | 2012-03-23 | 2012-03-27 | 10,000 | $5.08 | $50.8K | 9,616,794 | SEC↗ |
| Gutzwiller Felix | Director | A Award | 2012-03-23 | 2012-03-27 | 7,000 | $5.08 | $35.6K | 70,500 | SEC↗ |
| BARNHILL GREGORY HURD | Director | A Award | 2012-03-23 | 2012-03-27 | 5,000 | $5.08 | $25.4K | 82,421 | SEC↗ |
| MOYES JAY M | Director | A Award | 2012-03-23 | 2012-03-27 | 3,000 | $5.08 | $15.2K | 16,500 | SEC↗ |